Capital Research Global Investors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155M | Sell |
4,771,786
-1,338,322
| -22% | -$43.5M | 0.03% | 250 |
|
|
2025
Q1 | $231M | Sell |
6,110,108
-100,415
| -2% | -$3.79M | 0.05% | 206 |
|
|
2024
Q4 | $508M | Buy |
6,210,523
+1,312,302
| +27% | +$107M | 0.1% | 142 |
|
|
2024
Q3 | $560M | Buy |
4,898,221
+764,677
| +18% | +$87.4M | 0.12% | 134 |
|
|
2024
Q2 | $312M | Sell |
4,133,544
-6,977
| -0.2% | -$527K | 0.07% | 174 |
|
|
2024
Q1 | $283M | Buy |
4,140,521
+700,414
| +20% | +$47.8M | 0.06% | 200 |
|
|
2023
Q4 | $216M | Buy |
3,440,107
+75,980
| +2% | +$4.77M | 0.05% | 222 |
|
|
2023
Q3 | $172M | Hold |
3,364,127
| – | – | 0.05% | 243 |
|
|
2023
Q2 | $168M | Buy |
3,364,127
+511,121
| +18% | +$25.5M | 0.05% | 249 |
|
|
2023
Q1 | $107M | Buy |
2,853,006
+47,004
| +2% | +$1.76M | 0.03% | 271 |
|
|
2022
Q4 | $135M | Buy |
2,806,002
+2,291,146
| +445% | +$110M | 0.04% | 251 |
|
|
2022
Q3 | $12.7M | Buy |
+514,856
| New | +$12.7M | ﹤0.01% | 380 |
|